Life ScienceCompany
Bausch Health has acquired 40 companies, including 2 in the last 5 years. A total of 13 acquisitions came from private equity firms. It has also divested 10 assets.
Bausch Health’s largest acquisition to date was in 2015, when it acquired Salix Pharmaceuticals for $14.5B. It’s largest disclosed sale occurred in 2017, when it sold iNova Pharmaceuticals Pty to Pacific Equity Partners for $930M. Bausch Health has acquired in 10 different US states, and 11 countries. The Company’s most targeted sectors include life science (60%) and consumer products (18%).
Join Mergr and gain access to Bausch Health’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity45
- M&A Buy Activity35
- M&A Sell Activity10
- Total Sectors Invested 4
- Total Countries Invested 11
- M&A Buy/Sell Connections 34
- M&A Advisors 17
Unlimited Searches
